In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Alcon (ALC - Research Report), with a price target of $80.00. The company's shares closed yesterday at $67.94.According to TipRanks, Zimmerman is a 4-star analyst with an average return of 8.0% and a 44.74% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Vericel, Penumbra, and OrthoPediatrics.Currently, the analyst consensus on Alcon is a Moderate Buy with an average price target of $77.92, which is a 14.69% upside from current levels. In a report released on August 16, UBS also maintained a Buy rating on the stock with a CHF83.80 price target.
https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-alcon-alc-2?utm_source=advfn.com&utm_medium=referral
Alcon (NYSE:ALC)
Historical Stock Chart
Von Nov 2022 bis Dez 2022 Click Here for more Alcon Charts.
Alcon (NYSE:ALC)
Historical Stock Chart
Von Dez 2021 bis Dez 2022 Click Here for more Alcon Charts.